UTERINE CERVICAL NEOPLASMS
Clinical trials for UTERINE CERVICAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UTERINE CERVICAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UTERINE CERVICAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial aims to tame tough cancers
Disease control Recruiting nowThis early-stage trial tests a drug called sigvotatug vedotin, alone or with other medicines, in people with advanced solid tumors like lung, head and neck, or breast cancer. The goal is to find a safe dose and check for side effects. About 1,000 participants will join this study…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis trial tests a new drug called UCB4594, an antibody that targets a protein (HLA-G) found on many cancer cells. The goal is to see if it helps the immune system attack tumors. It is for people with advanced solid tumors (like lung, breast, or colon cancer) that have not respon…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
New hope for rare gynecological cancer: immunotherapy combo tested against chemo
Disease control Recruiting nowThis study tests whether the immunotherapy drug dostarlimab, given alone or with bevacizumab, works better than standard chemotherapy for people with recurrent gynecological clear cell carcinoma (a rare cancer of the ovary, uterus, cervix, vagina, or vulva). About 198 participant…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called LY4170156 in people with advanced solid tumors, such as ovarian, lung, and breast cancers. The drug is designed to target and kill cancer cells while sparing healthy ones. The trial has two parts: first to find the safest dose, then to see how w…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
AI-Powered camera could spot cervical cancer without a lab
Diagnosis Recruiting nowThis study is testing a new, low-cost screening tool for cervical cancer that uses artificial intelligence to analyze digital images of the cervix. It does not require a lab and can be used at the point of care. The goal is to see if this AI tool can accurately detect precancerou…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: NA • Sponsor: DL Analytics • Aim: Diagnosis
Last updated May 26, 2026 08:28 UTC
-
New study aims to stop cervical Pre-Cancer from coming back in HIV-Positive women
Knowledge-focused Recruiting nowThis study follows 250 women living with HIV in Zimbabwe who have been treated for cervical pre-cancer. Researchers want to find out how often the disease returns and which tests best predict that return. Participants will have regular check-ups and tests every six months for two…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated May 26, 2026 08:53 UTC
-
Can an MRI predict cancer treatment success? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at MRI scans from 120 women with advanced cervical cancer to see if a computer model can predict who will respond well to standard chemoradiotherapy. The goal is to identify women who might need different or stronger treatments early on. Researchers will analyze …
Matched conditions: UTERINE CERVICAL NEOPLASMS
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC
-
Video navigator aims to close cervical cancer screening gap
Knowledge-focused Recruiting nowThis study tests whether an interactive video program, paired with a community health worker, can help more African American women get screened for cervical cancer. About 288 women who are overdue for screening will be split into two groups: one gets the interactive video plus a …
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: NA • Sponsor: ISA Associates, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:30 UTC